David Goss, MD
Gynecology · The Villages, FLNPI 1154373033
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Merck at 56.5% of the total. Reporting peaked in 2019 at $3,469 and has fallen 97.5% since, to $87 in 2025.
Across 123 payments — averaging $46.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
- AbbVie$474
- Gynesonics, Inc.$281
- Medtronic$207
- Aspira Women's Health Inc$187
- Hologic Sales And Service, LLC$125
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$3,00053%
- Travel & lodging$962%
- Food & beverage$2,58045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $3,207 |
| AbbVie(2 entities) | 29 | $474 |
| Gynesonics, Inc. | 3 | $281 |
| Medtronic(2 entities) | 7 | $207 |
| Aspira Women's Health Inc | 3 | $187 |
| Hologic Sales And Service, LLC | 6 | $125 |
| Mayne Pharma Commercial LLC | 7 | $124 |
| Agile Therapeutics, Inc. | 6 | $109 |
| Organon | 6 | $86 |
| Coopersurgical, Inc. | 5 | $86 |
| Evofem Biosciences, Inc. | 4 | $79 |
| Meditrina | 4 | $76 |
| Exeltis, USA Inc. | 3 | $75 |
| Therapeuticsmd, Inc. | 4 | $73 |
| Astellas Pharma US Inc | 2 | $68 |
| Myriad Women's Health, Inc. | 1 | $62 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Bayer | 2 | $47 |
| Novo Nordisk | 2 | $37 |
| Pfizer | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Myovant Sciences Inc. | 2 | $30 |
| Exact Sciences | 2 | $28 |
| Avion Pharmaceuticals | 2 | $28 |
| Roche Diagnostics Corporation | 1 | $20 |
| Axonics, Inc. | 1 | $16 |
| Lupin Inc. | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,677 in reported general payments places this provider in the 85th percentile of 290 gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $1,627 |
| ProgesteroneProgesterone, Micronized | 16 | $982 |
Paid to pharmacies, not to this prescriber.
Other gynecology in The Villages
- Andrea GallowayThe Villages$252K
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Meenakshi JainSt Petersburg$35K
- Michael SpragueWeston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.